Today's Hours: 10:00am - 6:00pm

Search

Did You Mean:

Search Results

  • Book
    edited by Andras Nagy, Kursad Turksen.
    Contents:
    Generation of patient-specific induced pluripotent stem cell from peripheral blood mononuclear cells by Sendai reprogramming vectors / Oscar Quintana-Bustamante and Jose C. Segovia
    Doxycycline-inducible system for genetic correction of iPSC disease models / Xiuli Sim ... [et al.]
    Generation and characterization of patient-specific induced pluripotent stem cell for disease modeling / Renuka Sivapatham and Xianmin Zeng
    Modeling genomic imprinting disorders using induced pluripotent stem cells / Stormy J. Chamberlain ... [et al.]
    Generation and characterization of induced pluripotent stem cells from patients with mtDNA mutations / Riikka H. Hssamssalssainen and Anu Suomalainen
    Skin biopsy and patient-specific stem cell lines / Yao Li, Huy V. Nguyen, and Stephen H. Tsang
    Directed myogenic differentiation of human induced pluripotent stem cells / Emi Shoji, Knut Woltjen, and Hidetoshi Sakurai
    Using human induced pluripotent stem cells to model skeletal diseases / Emilie Barruet and Edward C. Hsiao
    Modeling cardiovascular diseases with patient-specific human pluripotent stem cell-derived cardiomyocytes / Paul W. Burridge ... [et al.]
    Calcium imaging in pluripotent stem cell-derived cardiac myocytes / Anna Walter ... [et al.]
    Patient-specific induced pluripotent stem cell models : generation and characterization of cardiac cells / Fabian Zanella and Farah Sheikh
    Differentiation of human pluripotent stem cells to cardiomyocytes under defined conditions / Cathelijne W. van den Berg ... [et al.]
    Generation of cardiomyocytes from pluripotent stem cells / Hiroko Nakahama and Elisa Di Pasquale
    Generation and characterization of patient-specific iPSC model for cardiovascular disease / Yee Ki Lee ... [et al.]
    Transgene-free disease-specific iPSC generation from fibroblasts and peripheral blood mononuclear cells / Kerem Fidan ... [et al.]
    Generation and neuronal Differentiation of patient-specific induced pluripotent stem cells derived from Niemann-Pick type C1 fibroblasts / Michaela Trilck, Rayk Hubner, and Moritz J. Frech
    Multisystemic disease modeling of liver-derived protein folding disorders using induced pluripotent stem cells (iPSCs) / Amy Leung and George J. Murphy
    In vitro modeling of alcohol-induced liver injury using human-induced pluripotent stem cells / Lipeng Tian, Neha Prasad, and Yoon-Young Jang
    Generation of human induced pluripotent stem cells using RNA-based sendai virus system and pluripotency validation of the resulting cell population / Valeria Chichagova ... [et al.]
    Modeling axonal phenotypes with human pluripotent stem cells / Kyle R. Denton, Chong-Chong Xu, and Xue-Jun Li
    Mitochondrial disease-specific induced pluripotent stem cell models : generation and characterization / Xuan Zhang ... [et al.]
    Patient-specific induced pluripotent stem cell models : characterization of iPS cell-derived cardiomyocytes / Toru Egashira ... [et al.]
    Generation of integration-free patient specific iPS cells using episomal plasmids under feeder free conditions / Sara Caxaria ... [et al.].
    Digital Access Springer 2016
  • Article
    Cornish EC, Cussen CM, Hird FJ, Todd PE.
    Comp Biochem Physiol B. 1978;61(3):375-8.
    1. The activities of aminotransferases catalysing the transfer of amino groups from aspartate, alanine and leucine to 2-oxoglutarate in different tissues of the rat, pigeon and trout have been determined. 2. Alanine-2-oxoglutarate aminotransferase was high in the liver of the rat and trout and low in that of the pigeon. 3. Aspartate-2-oxoglutarate aminotransferase was usually the dominant aminotransferase in all tissues and was highest in oxidative tissues where the TCA cycle is active. Its activity in the various livers is not correlated with the function of aspartate in nitrogen excretion. 4. The activity of aspartate-2-oxoglutarate aminotransferase in oxidative tissues argues that aspartate in conjunction with this enzyme serves as a buffer of oxaloacetate to keep the TCA cycle running and/or to mediate the transfer of reducing equivalents across mitochondrial membranes.
    Digital Access Access Options